Last year, a study in South Africa involved the only vaccine candidate that showed protection, was ultimately not effective enough.
Explainer: What the indemnity clause is and how its waiver will accelerate COVID-19 vaccine process in India
Given that Pfizer's mRNA vaccine is the only jab to have been approved for use in children aged 12 and 17, the 50 million doses the govt aiming to procure should be allow India vaccinate most of its children in that age group
Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official
"The data is coming in, and it looks very encouraging that the US-approved vaccines do have effectiveness against this variant called B1617," Dr Francis Collins, Director of the National Institute of Science said
Moderna and Johnson & Johnson are also conducting trials of its vaccine in teens and younger children as well.
Federal health officials decided that J&J's one-and-done vaccine is critical to fight the pandemic after scientific advisers said its benefits outweigh the risks
India fast-tracks EUA for foreign-produced COVID vaccines amid spike in cases: A look at all the options
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin
Dr Reddy's conducted the bridge trials in India and will distribute some 100 million doses of the vaccine in India.
In 2021, Johnson & Johnson promised to supply 200 million doses to Covax and will supply another 300 million to Covax in 2022.
COVID-19 Vaccine Update: Harvard studies show DNA vaccines provide partial immunity and antibodies prevent reinfection
One thing that the world didn’t know so far was if an infected person who recovers from the infection is safe from reinfection.
Faulty hip implants: Delhi HC asks Johnson & Johnson for interim payment of Rs 25 lakh to 4 patients
The court's direction came after Johnson & Johnson said it was willing to pay Rs 25 lakh as compensation to the patients who were affected by the implants.
Johnson and Johnson faulty implants: Supreme Court closes case, asks Centre to 'widely' publicise compensation scheme
A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a compensation scheme has been formulated by it to ensure proper compensation to the victims of faulty hip implants by Johnson and Johnson
There is an urgent need for a more accessible scheme that provides people outside the metropolises with sustainable tuberculosis treatment
National Commission for Protection of Child Rights has asked five states to collect the samples of Johnson and Johnson baby powder and shampoo for testing.
For the second time, Johnson and Johnson has paid millions of dollars in damages to women with claims that the company was negligent in warning users that prolonged use of its baby powder could increase risk of ovarian cancer
FIPB has cleared foreign invest in 11 entities, worth Rs 1,075.91 cr, referred proposals worth Rs 4,187 crore in firms - Glenmark and Aurobindo - to CCEA
Coming up on 48 acres, the plant will be operational from 2016 and will employ 1,500 people. It will manufacture hygiene and consumer goods products.
The FDA has spotted ethylene oxide, a carcinogen and irritant, in 15 batches of baby talcum powder produced in 2007 and had shelf life until 2010.